AMI ORGANICS | GLENMARK PHARMA | AMI ORGANICS/ GLENMARK PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 90.4 | -31.4 | - | View Chart |
P/BV | x | 6.8 | 2.9 | 237.8% | View Chart |
Dividend Yield | % | 0.3 | 0.3 | 105.0% |
AMI ORGANICS GLENMARK PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AMI ORGANICS Mar-23 |
GLENMARK PHARMA Mar-23 |
AMI ORGANICS/ GLENMARK PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,182 | 487 | 242.7% | |
Low | Rs | 826 | 349 | 236.7% | |
Sales per share (Unadj.) | Rs | 169.2 | 460.4 | 36.8% | |
Earnings per share (Unadj.) | Rs | 22.9 | 13.4 | 170.9% | |
Cash flow per share (Unadj.) | Rs | 26.2 | 35.0 | 74.9% | |
Dividends per share (Unadj.) | Rs | 3.00 | 2.50 | 120.0% | |
Avg Dividend yield | % | 0.3 | 0.6 | 50.0% | |
Book value per share (Unadj.) | Rs | 163.0 | 335.1 | 48.6% | |
Shares outstanding (eoy) | m | 36.44 | 282.17 | 12.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 5.9 | 0.9 | 653.4% | |
Avg P/E ratio | x | 43.9 | 31.3 | 140.6% | |
P/CF ratio (eoy) | x | 38.3 | 11.9 | 320.7% | |
Price / Book Value ratio | x | 6.2 | 1.2 | 493.9% | |
Dividend payout | % | 13.1 | 18.7 | 70.2% | |
Avg Mkt Cap | Rs m | 36,590 | 117,953 | 31.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 488 | 27,810 | 1.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,167 | 129,901 | 4.7% | |
Other income | Rs m | 43 | 3,168 | 1.4% | |
Total revenues | Rs m | 6,211 | 133,069 | 4.7% | |
Gross profit | Rs m | 1,226 | 15,125 | 8.1% | |
Depreciation | Rs m | 123 | 6,113 | 2.0% | |
Interest | Rs m | 24 | 3,496 | 0.7% | |
Profit before tax | Rs m | 1,122 | 8,685 | 12.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 289 | 4,911 | 5.9% | |
Profit after tax | Rs m | 833 | 3,774 | 22.1% | |
Gross profit margin | % | 19.9 | 11.6 | 170.7% | |
Effective tax rate | % | 25.7 | 56.5 | 45.5% | |
Net profit margin | % | 13.5 | 2.9 | 464.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 4,701 | 98,737 | 4.8% | |
Current liabilities | Rs m | 1,628 | 50,455 | 3.2% | |
Net working cap to sales | % | 49.8 | 37.2 | 134.0% | |
Current ratio | x | 2.9 | 2.0 | 147.5% | |
Inventory Days | Days | 5 | 7 | 71.7% | |
Debtors Days | Days | 1,363 | 115 | 1,183.3% | |
Net fixed assets | Rs m | 2,969 | 76,920 | 3.9% | |
Share capital | Rs m | 364 | 282 | 129.1% | |
"Free" reserves | Rs m | 5,575 | 94,281 | 5.9% | |
Net worth | Rs m | 5,940 | 94,563 | 6.3% | |
Long term debt | Rs m | 6 | 38,521 | 0.0% | |
Total assets | Rs m | 7,669 | 175,658 | 4.4% | |
Interest coverage | x | 47.5 | 3.5 | 1,363.4% | |
Debt to equity ratio | x | 0 | 0.4 | 0.3% | |
Sales to assets ratio | x | 0.8 | 0.7 | 108.7% | |
Return on assets | % | 11.2 | 4.1 | 270.0% | |
Return on equity | % | 14.0 | 4.0 | 351.4% | |
Return on capital | % | 19.3 | 9.2 | 210.6% | |
Exports to sales | % | 59.1 | 0 | - | |
Imports to sales | % | 30.3 | 0 | - | |
Exports (fob) | Rs m | 3,644 | NA | - | |
Imports (cif) | Rs m | 1,866 | NA | - | |
Fx inflow | Rs m | 3,644 | 46,464 | 7.8% | |
Fx outflow | Rs m | 1,866 | 12,712 | 14.7% | |
Net fx | Rs m | 1,777 | 33,751 | 5.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 655 | 6,254 | 10.5% | |
From Investments | Rs m | -330 | -5,285 | 6.3% | |
From Financial Activity | Rs m | -123 | -775 | 15.8% | |
Net Cashflow | Rs m | 202 | 325 | 62.3% |
Indian Promoters | % | 39.9 | 46.7 | 85.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 19.2 | 34.7 | 55.5% | |
FIIs | % | 11.7 | 23.7 | 49.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 60.1 | 53.4 | 112.6% | |
Shareholders | 83,344 | 209,931 | 39.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare AMI ORGANICS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | AMI ORGANICS | Glenmark Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.65% | -0.57% | 1.18% |
1-Month | -2.94% | 5.16% | -0.75% |
1-Year | 22.47% | 112.94% | 61.82% |
3-Year CAGR | 5.40% | 27.51% | 18.16% |
5-Year CAGR | 3.21% | 8.05% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the AMI ORGANICS share price and the Glenmark Pharma share price.
Moving on to shareholding structures...
The promoters of AMI ORGANICS hold a 39.9% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AMI ORGANICS and the shareholding pattern of Glenmark Pharma.
Finally, a word on dividends...
In the most recent financial year, AMI ORGANICS paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 13.1%.
Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.
You may visit here to review the dividend history of AMI ORGANICS, and the dividend history of Glenmark Pharma.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.